BusinessAchillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory AffairsBy Nasdaq OMXFeb 3, 2016, 11:05 AM UTC
BusinessAchillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology and Nomination of ACH-4471, a Novel Small Molecule Factor D Inhibitor, for Clinical DevelopmentBy Nasdaq OMXDec 5, 2015, 10:00 PM UTC
